I am a
Home I AM A Search Login

Papers of the Week

Papers: 22 Oct 2022 - 28 Oct 2022

Pharmacology/Drug Development

2022 Oct 27

Pain Pract

Gabapentin-Friend or foe?


Russo M, Graham B, Santarelli DM
Pain Pract. 2022 Oct 27.
PMID: 36300903.


Gabapentin is a recommended first-line agent for treating neuropathic pain; however, its efficacy rate is reportedly low, and the risk of adverse events is high. A plausible explanation for this lies with its wide range of actions, the entirety of which have yet to be fully elucidated.